Symposium

To view a recording of the 2020 Warren Alpert Prize Symposium, click here.

Cardiometabolic Medicines From the Gut: The Glucagon-Like Peptide Story

In honor of Daniel Drucker, Joel Habener, Jens Juul Holst

for identifying the family of Glucagon-Like Peptides through studies extending from cells to humans, culminating in the development of these peptides and related pathway-modifiers as important new classes of  therapeutic agents for treating diabetes, obesity and short bowel syndrome.

Featured Speakers Include:

Fiona Gribble, DPhil, BM, BCh
Professor of Endocrine Physiology
WT-MRC Institute of Metabolic Science
University of Cambridge
Gut endocrine cells - chemosensors of the postprandial state

Jens Juul Holst, MD, DMSc
Professor, Department of Biomedical Sciences and Group Leader
Translational Metabolic Physiology, Novo Nordisk Foundation Center for Basic Metabolic Research
University of Copenhagen
GLP-1 in humans

Joel Habener, MD
Professor of Medicine, Harvard Medical School
Director of the Laboratory of Molecular Endocrinology, Massachusetts General Hospital
Glucagon-like Peptide-1: Discovery, Structure, Activity

Daniel Drucker, MD
Senior Scientist, the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada,
Professor of Medicine, University of Toronto
The protean peptide GLP-1; From metabolism to inflammation and cardioprotection

Matthias H. Tschöp, MD
Alexander von Humboldt Professor, Technical University of Munich
Chief Executive Officer and Scientific Director, Helmholtz Center Munich
Glucagon-like polyagonists - discovery, mechanism and clinical translation